Mercaptopurine from Germany
Mercaptopurine (6-MP) is a purine antimetabolite chemotherapy drug with thiopurine heterocyclic structure, used in leukemia treatment. Falls under HTS 2934.99.4700 as organo-sulfur heterocyclic drug, excluded from heading 2930 by classification notes. Light-sensitive pharmaceutical requiring special handling.
Duty Rate — Germany → United States
21.3%
Rate breakdown
9903.04.6211.3%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.3910%Except for products described in headings 9903.05.85–9903.05.92 and 9903.05.97, articles the product of a member state of the European Union, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 10 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Light-protected packaging mandatory; oncology GMP certification; genetic testing data may be required for pharmacogenomics compliance